Hérault JP - Search Results

1

Investigation of the selectivity of thrombin-binding aptamers for thrombin titration in murine plasma.

Trapaidze A, Hérault JP, Herbert JM, Bancaud A, Gué AM. Trapaidze A, et al. Among authors: herault jp. Biosens Bioelectron. 2016 Apr 15;78:58-66. doi: 10.1016/j.bios.2015.11.017. Epub 2015 Nov 10. Biosens Bioelectron. 2016. PMID: 26594887

2

Effect of clopidogrel on thrombin generation in platelet-rich plasma in the rat.

Hérault JP, Dol F, Gaich C, Bernat A, Herbert JM. Hérault JP, et al. Thromb Haemost. 1999 Jun;81(6):957-60. Thromb Haemost. 1999. PMID: 10404775

3

5-Chlorothiophene-2-carboxylic acid [(S)-2-[2-methyl-3-(2-oxopyrrolidin-1-yl)benzenesulfonylamino]-3-(4-methylpiperazin-1-yl)-3-oxopropyl]amide (SAR107375), a selective and potent orally active dual thrombin and factor Xa inhibitor.

Meneyrol J, Follmann M, Lassalle G, Wehner V, Barre G, Rousseaux T, Altenburger JM, Petit F, Bocskei Z, Schreuder H, Alet N, Herault JP, Millet L, Dol F, Florian P, Schaeffer P, Sadoun F, Klieber S, Briot C, Bono F, Herbert JM. Meneyrol J, et al. Among authors: herault jp. J Med Chem. 2013 Dec 12;56(23):9441-56. doi: 10.1021/jm4005835. Epub 2013 Dec 3. J Med Chem. 2013. PMID: 24175584

4

Antithrombin-mediated inhibition of factor VIIa-tissue factor complex by the synthetic pentasaccharide representing the heparin binding site to antithrombin.

Lormeau JC, Herault JP, Herbert JM. Lormeau JC, et al. Among authors: herault jp. Thromb Haemost. 1996 Jul;76(1):5-8. Thromb Haemost. 1996. PMID: 8819242

5

A unique trisaccharide sequence in heparin mediates the early step of antithrombin III activation.

Petitou M, Barzu T, Herault JP, Herbert JM. Petitou M, et al. Among authors: herault jp. Glycobiology. 1997 Apr;7(3):323-7. doi: 10.1093/glycob/7.3.323-e. Glycobiology. 1997. PMID: 9147040

6

Comparative effects of two direct and indirect factor Xa inhibitors on free and clot-bound prothrombinase.

Hérault JP, Bernat A, Pflieger AM, Lormeau JC, Herbert JM. Hérault JP, et al. J Pharmacol Exp Ther. 1997 Oct;283(1):16-22. J Pharmacol Exp Ther. 1997. PMID: 9336303

7

Effect of SR121566A, a potent GP IIb-IIIa antagonist on platelet-mediated thrombin generation in vitro and in vivo.

Herault JP, Peyrou V, Savi P, Bernat A, Herbert JM. Herault JP, et al. Thromb Haemost. 1998 Feb;79(2):383-8. Thromb Haemost. 1998. PMID: 9493595

8

Contribution of erythrocytes to thrombin generation in whole blood.

Peyrou V, Lormeau JC, Hérault JP, Gaich C, Pfliegger AM, Herbert JM. Peyrou V, et al. Among authors: herault jp. Thromb Haemost. 1999 Mar;81(3):400-6. Thromb Haemost. 1999. PMID: 10102469

9

Synthesis of thrombin-inhibiting heparin mimetics without side effects.

Petitou M, Hérault JP, Bernat A, Driguez PA, Duchaussoy P, Lormeau JC, Herbert JM. Petitou M, et al. Among authors: herault jp. Nature. 1999 Apr 1;398(6726):417-22. doi: 10.1038/18877. Nature. 1999. PMID: 10201371

10

Pharmacokinetics of new synthetic heparin mimetics.

Hérault JP, Bernat A, Roye F, Michaux C, Schaeffer P, Bono F, Petitou M, Herbert JM. Hérault JP, et al. Thromb Haemost. 2002 Jun;87(6):985-9. Thromb Haemost. 2002. PMID: 12083506

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

69 results

Search Page